Dataset from A Double-blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Adalimumab in Pediatric Subjects With Enthesitis Related Arthritis
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00003067
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the efficacy and safety of adalimumab given subcutaneously every other week (eow) as compared to placebo in pediatric subjects with Enthesitis Related Arthritis (ERA).
本研究旨在评估每两周皮下注射阿达木单抗（adalimumab，eow）对比安慰剂，治疗附着点炎相关关节炎（Enthesitis Related Arthritis，ERA）儿科受试者的有效性与安全性
创建时间：
2025-03-04
